Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v22-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2022-05-20 | 2022-01-07 |
| Drug Identification Number | 02248239 | 02248239 |
| Brand name | ELIGARD | ELIGARD |
| Common or Proper name | Leuprolide acetate for injection | Leuprolide acetate for injection |
| Company Name | TOLMAR INTERNATIONAL LTD. | TOLMAR INTERNATIONAL LTD. |
| Ingredients | LEUPROLIDE ACETATE | LEUPROLIDE ACETATE |
| Strength(s) | 7.5MG | 7.5MG |
| Dosage form(s) | POWDER FOR SUSPENSION, EXTENDED-RELEASE | POWDER FOR SUSPENSION, EXTENDED-RELEASE |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 Carton / Kit | 1 Carton / Kit |
| ATC code | L02AE | L02AE |
| ATC description | HORMONES AND RELATED AGENTS | HORMONES AND RELATED AGENTS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2022-01-21 | 2022-01-21 |
| Actual start date | 2022-01-24 | |
| Estimated end date | 2022-06-10 | 2022-02-14 |
| Actual end date | 2022-05-20 | |
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ELIGARD® 22.5 mg, 30 mg and 45 mg are available. | ELIGARD® 22.5 mg, 30 mg and 45 mg are available. |
| Health Canada comments |